Clarification regarding Intervacc's vaccine Strangvac
Stockholm, December 17, 2021 - Due to the large and volatile trading in the company's share based on speculations on social media, Intervacc wants to clarify that Strangvac is centrally approved by EMA for sales throughout the EU and that sales will start during the first quarter of 2022.
Strangvac is centrally approved for sale throughout the EU, including Sweden, for vaccination of horses against the contagious bacterial disease strangles. Strangvac was unanimously approved by all Member States after an extensive evaluation process lasting 15 months. This means that the vaccine is safe,